The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schell, T. D.
Right arrow Articles by Tevethia, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schell, T. D.
Right arrow Articles by Tevethia, S. S.
The Journal of Immunology, 2001, 167: 6947-6956.
Copyright © 2001 by The American Association of Immunologists

Control of Advanced Choroid Plexus Tumors in SV40 T Antigen Transgenic Mice Following Priming of Donor CD8+ T Lymphocytes by the Endogenous Tumor Antigen1

Todd D. Schell2 and Satvir S. Tevethia

Department of Microbiology and Immunology, Pennsylvania State University College of Medicine, Hershey, PA 17033

Mouse models in which tumors arise spontaneously due to the transgenic expression of an oncoprotein provide an opportunity to test approaches that target the immune-mediated control of tumor progression. In this report we investigated the role of SV40 Tag-specific CD8+ T cells in the control of advanced choroid plexus tumor progression using large tumor Ag (Tag) transgenic mice. Since mice of the SV11 line are tolerant to the immunodominant SV40 Tag-derived CTL epitopes, mice with advanced stage tumors were reconstituted with naive C57BL/6 spleen cells following a low dose of {gamma}-irradiation. This led to the priming of CTLs specific for the H2-Kb-restricted epitope IV by the endogenous Tag and a significant increase in the life span of Tag transgenic mice. Epitope IV-specific CD8+ T cells accumulated and persisted in the brains and tumors of SV11 mice, as determined by analysis with epitope-specific MHC class I tetramers. Brain-infiltrating epitope IV-specific T cells were capable of producing IFN-{gamma} as well as lysing syngeneic Tag-transformed cells in vitro. In addition, the adoptive transfer of spleen cells from Tag-immune C57BL/6 mice resulted in a dramatic increase in the control of tumor progression in SV11 mice and was associated with the accumulation of CD8+ T cells specific for multiple Tag epitopes in the brain. These results indicate that the control of advanced stage spontaneous choroid plexus tumors is associated with the induction of a strong and persistent CD8+ T cell response to Tag.




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. Hamzah, J. G. Altin, T. Herringson, C. R. Parish, G. J. Hammerling, H. O'Donoghue, and R. Ganss
Targeted Liposomal Delivery of TLR9 Ligands Activates Spontaneous Antitumor Immunity in an Autochthonous Cancer Model
J. Immunol., July 15, 2009; 183(2): 1091 - 1098.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. M. Tatum, L. M. Mylin, S. J. Bender, M. A. Fischer, B. A. Vigliotti, M. J. Tevethia, S. S. Tevethia, and T. D. Schell
CD8+ T Cells Targeting a Single Immunodominant Epitope are Sufficient for Elimination of Established SV40 T Antigen-Induced Brain Tumors
J. Immunol., September 15, 2008; 181(6): 4406 - 4417.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Otahal, B. B. Knowles, S. S. Tevethia, and T. D. Schell
Anti-CD40 Conditioning Enhances the TCD8 Response to a Highly Tolerogenic Epitope and Subsequent Immunotherapy of Simian Virus 40 T Antigen-Induced Pancreatic Tumors
J. Immunol., November 15, 2007; 179(10): 6686 - 6695.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Otahal, T. D. Schell, S. C. Hutchinson, B. B. Knowles, and S. S. Tevethia
Early Immunization Induces Persistent Tumor-Infiltrating CD8+ T Cells against an Immunodominant Epitope and Promotes Lifelong Control of Pancreatic Tumor Progression in SV40 Tumor Antigen Transgenic Mice.
J. Immunol., September 1, 2006; 177(5): 3089 - 3099.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. M. Ryan and T. D. Schell
Accumulation of CD8+ T Cells in Advanced-Stage Tumors and Delay of Disease Progression following Secondary Immunization against an Immunorecessive Epitope
J. Immunol., July 1, 2006; 177(1): 255 - 267.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Garbi, B. Arnold, S. Gordon, G. J. Hammerling, and R. Ganss
CpG Motifs as Proinflammatory Factors Render Autochthonous Tumors Permissive for Infiltration and Destruction
J. Immunol., May 15, 2004; 172(10): 5861 - 5869.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. D. Schell
In Vivo Expansion of the Residual Tumor Antigen-Specific CD8+ T Lymphocytes That Survive Negative Selection in Simian Virus 40 T-Antigen-Transgenic Mice
J. Virol., February 15, 2004; 78(4): 1751 - 1762.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. L. Garcea and M. J. Imperiale
Simian Virus 40 Infection of Humans
J. Virol., May 1, 2003; 77(9): 5039 - 5045.
[Full Text] [PDF]


Home page
J. Immunol.Home page
X. Zheng, J.-X. Gao, H. Zhang, T. L. Geiger, Y. Liu, and P. Zheng
Clonal Deletion of Simian Virus 40 Large T Antigen-Specific T Cells in the Transgenic Adenocarcinoma of Mouse Prostate Mice: An Important Role for Clonal Deletion in Shaping the Repertoire of T Cells Specific for Antigens Overexpressed in Solid Tumors
J. Immunol., November 1, 2002; 169(9): 4761 - 4769.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. Velupillai, J. P. Carroll, and T. L. Benjamin
Susceptibility to Polyomavirus-Induced Tumors in Inbred Mice: Role of Innate Immune Responses
J. Virol., August 28, 2002; 76(19): 9657 - 9663.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
T. D. Schell, L. M. Mylin, S. S. Tevethia, and S. Joyce
The assembly of functional {beta}2-microglobulin-free MHC class I molecules that interact with peptides and CD8+ T lymphocytes
Int. Immunol., July 1, 2002; 14(7): 775 - 782.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.